Symbolic Rebirth Ahead of Clinical Trials for Sickle Cell Disease and Thalassemia

San Rocco Therapeutics (SRT) proudly announces the revitalization of the European company headquarters in Altamura, Italy and the artistic makeover of the three huge statues which surround the edifice, in preparation for Sickle Cell Disease and Thalassemia clinical trials.

Megan Euker, acclaimed artist and SRT project manager, in July made the trip from the US company headquarters in Tampa, Florida to the original SRT facility in Altamura, Italy where 38 patients were treated with the groundbreaking fetal hemoglobin gene enhancer, Arginine Butyrate.

The center’s 1995 inauguration featured the participation of world-renowned hematologist-oncologist and Italy’s surgeon general, Dr. Franco Locatelli, marking the beginning of his collaboration with SRT. Now, 30 years later, SRT is honored that Dr. Locatelli will serve as Principal Investigator for its upcoming European trial, treating patients at Bambino Gesù Children’s Hospital in Rome, bringing the story full circle.

View the rest of the article here

View the PDF

Leggi la versione italiana

Leggi la versione italiana PDF